logo
Share SHARE
FONT-SIZE Plus   Neg

Endo Buys US Patent For Oxymorphone From Johnson Matthey - Quick Facts

Endo Pharmaceuticals Holdings (ENDP) said it has acquired U.S. patent for oxymorphone hydrochloride, the key API in all formulations of OPANA, from Johnson Matthey plc (JMAT.L).

By acquiring Johnson Matthey's patent to the oxymorphone ingredient, which will be listed in the U.S. Food and Drug Administration's Orange Book, Endo will enjoy additional patent protection for its OPANA franchise, now through 2029.

"This patent not only covers our newly designed to be crush resistant OPANA® ER, it covers all products that include oxymorphone that are manufactured in accordance with current FDA specifications," said Julie McHugh, chief operating officer of Endo.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Google rebranded Thursday its business-to-business cloud computing brand as Google Cloud and also enhanced some enterprise applications with new intelligent capabilities. Google Cloud brand includes Google's all cloud services, including the Google Cloud Platform, enterprise mobility, and Chromebooks. Google Apps for Work has been named as G Suite. Can a washing machine explode just like a bomb? A lawsuit filed in the federal court in New Jersey alleged that there was loud noise and damage to garage wall as the washing machine went off with a violent boom. Samsung is facing federal class action lawsuit from customers. There were similar reports... German lender Commerzbank AG said Thursday that it will cut almost 10,000 jobs, stop paying dividends for the time being and merge two big units as part of a restructuring to become profitable on a sustainable basis by 2020. The bank, Germany's second largest, said that to cover its restructuring costs in the region of 1.1 billion euros, it will cease dividend payments for the time being.
comments powered by Disqus
Follow RTT